Sai Parenterals Limited has informed the Exchange regarding 'Intimation under Regulation 30(5) of SEBI'.
SAIPARENT · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sai Parenterals Limited has informed the stock exchanges (BSE and NSE) about the Key Managerial Personnel authorized under Regulation 30(5) of SEBI LODR Regulations, 2015. Three senior officials have been severally authorized to determine materiality of events/information and make disclosures to stock exchanges: Anil Kumar Karusala (Chairman and Managing Director), Anil Kumar (Chief Financial Officer), and Shivali Aggarwal (Company Secretary and Compliance Officer). The filing is dated April 6, 2026, and is signed by the Managing Director. All three persons can act independently in their authorized capacity.
No direct impact on stock price or shareholder value. This is a routine compliance filing updating the exchanges on authorized signatories for regulatory disclosures. It ensures the company has proper channels for market-sensitive announcements.